Clinical Trial Update: Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial CATIS-ICAS evaluating combination antithrombotic therapy to prevent recurrent ischemic stroke in intracranial atherosclerosis. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerosis
• Stroke

Snippet

Sponsor: Population Health Research Institute | Conditions: Ischemic Stroke, Intracranial Atherosclerosis | Phase 3 | Status: NOT_YET_RECRUITING